BCIQ Profiles

Company Profile ReportTarget Profile Report

Antibacterial company Entasis proposes NASDAQ IPO

Entasis Therapeutics Inc. (Waltham, Mass.) proposed on Aug. 17 to raise $86.3 million in an IPO on NASDAQ underwritten by Credit Suisse, BMO Capital Markets, SunTrust Robinson

Read the full 278 word article

How to gain access

Continue reading with a
two-week free trial.